Does Medicare Cover GLP-1 Drugs for Weight Loss in 2026?
Medicare now provides access to certain GLP-1 weight-loss medications for some Part D beneficiaries through the Medicare GLP-1 Bridge. The program started July 1, 2026 and is currently scheduled through December 31, 2027. Eligible beneficiaries pay $50 for a monthly supply. Current Bridge drugs include Foundayo, Wegovy and the Zepbound KwikPen formulation. Eligibility is not automatic: you need Medicare Part D coverage, must meet clinical criteria and generally cannot already be receiving a GLP-1 through your Part D plan.
Does Medicare Cover GLP-1 Drugs for Weight Loss?
The answer changed significantly in 2026.
Medicare historically excluded drugs when used solely for weight loss under the standard Part D benefit.
However, CMS launched the Medicare GLP-1 Bridge on July 1, 2026.
The Bridge is a short-term Medicare demonstration designed to give certain Part D beneficiaries access to selected GLP-1 medications for reducing excess body weight and maintaining weight reduction.
July 1, 2026 – December 31, 2027
Which GLP-1 Drugs Does the Medicare Bridge Cover?
CMS currently lists the following products for qualifying weight-management use:
| Medication | Bridge Coverage | Important Detail |
|---|---|---|
| Wegovy | Yes | CMS includes injection and tablet formulations currently listed for the Bridge. |
| Zepbound | Yes, limited formulation | KwikPen only. Single-dose Zepbound pens and vials are not included. |
| Foundayo | Yes | Current eligible formulations are included. |
| Ozempic | Not as a Bridge weight-loss drug | May be covered through ordinary Part D for a qualifying medically accepted indication. |
| Mounjaro | Not as a Bridge weight-loss drug | May be covered through ordinary Part D for a qualifying medically accepted indication. |
How Much Do GLP-1 Drugs Cost Through the Medicare Bridge?
Eligible beneficiaries pay a $50 copay for a monthly supply of an eligible Bridge medication.
CMS says the $50 amount applies regardless of income level.
Does the Part D Deductible Apply to the $50?
No.
The Medicare GLP-1 Bridge operates outside the normal Part D benefit coverage and payment flow.
CMS therefore says the Part D deductible does not apply to eligible drugs obtained through the Bridge.
Does the $50 Count Toward My Part D Out-of-Pocket Limit?
No.
CMS says the $50 Bridge copay does not count toward TrOOP (True Out-of-Pocket) costs.
That means paying $50 through the Bridge does not move you closer to your normal Part D annual out-of-pocket threshold.
The Bridge operates outside the standard Part D payment flow. The Part D deductible does not apply and the $50 does not count toward TrOOP.
Who Qualifies for the Medicare GLP-1 Bridge?
CMS has several eligibility requirements.
First, you must have Medicare Part D prescription-drug coverage.
That can be through:
- A standalone Medicare drug plan, or
- An eligible Medicare health plan that includes Part D drug coverage.
You must also meet the program’s medical and coverage requirements.
What BMI Is Required?
According to Medicare’s current beneficiary guidance, you must be at least 18 years old and satisfy at least one of these clinical pathways:
| BMI | Additional Requirement |
|---|---|
| 35 or higher | No additional condition from the lower-BMI pathways is required. |
| 30 or higher | Certain heart failure, difficult-to-control high blood pressure, or chronic kidney disease stage 3a or above. |
| 27 or higher | Prediabetes, or a history of heart attack, stroke, or blocked arteries in the arms or legs. |
Your healthcare provider determines the relevant clinical information and submits the required prior authorization.
Is Prior Authorization Required?
Yes.
A healthcare provider must submit a prior authorization request for access through the Medicare GLP-1 Bridge.
The authorization process confirms whether the beneficiary meets the Bridge’s eligibility and clinical requirements.
Your healthcare provider needs to submit the required prior authorization for the Bridge.
Can I Use the Bridge If Medicare Already Covers My GLP-1?
Generally, no.
The Bridge was designed for eligible beneficiaries who do not already have access to a GLP-1 through their Part D benefit.
CMS says that if you have already received a GLP-1 paid for by your Medicare drug plan during the relevant 2026 period, you should generally continue obtaining the medication through your Part D plan rather than through the Bridge.
What If I Have Type 2 Diabetes?
This is an especially important eligibility distinction.
CMS says people with type 2 diabetes are not eligible for the GLP-1 Bridge.
If you have type 2 diabetes, your Part D plan may already cover an appropriate GLP-1 medication for that medical indication.
Contact your Medicare drug plan to check its formulary and coverage rules.
What If I Have Sleep Apnea?
CMS also excludes people with moderate-to-severe obstructive sleep apnea from Bridge eligibility.
That’s because certain GLP-1 treatment may already fall within ordinary Part D coverage rules for an FDA-approved medically accepted indication.
What About Fatty Liver Disease?
CMS’s current criteria also exclude certain beneficiaries with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate-to-advanced liver fibrosis.
Medicare’s consumer materials may describe this more simply as fatty liver disease.
If this applies to you, contact your Part D plan about ordinary drug coverage rather than assuming the Bridge is your coverage route.
Does Medicare Cover Ozempic for Weight Loss?
Ozempic is not currently one of the medications CMS lists as a Bridge drug for weight management.
However, that does not mean Medicare never covers Ozempic.
Part D may cover Ozempic for an appropriate medically accepted indication, such as treatment associated with type 2 diabetes, subject to the plan’s formulary and utilization rules.
A drug may be covered by Part D for one FDA-approved medically accepted indication while not being available through the Bridge for weight management.
Does Medicare Cover Mounjaro for Weight Loss?
Mounjaro is also not currently listed as a Medicare GLP-1 Bridge weight-management medication.
Mounjaro may instead be covered under normal Part D rules for an appropriate medically accepted indication such as type 2 diabetes, depending on the plan.
Does Medicare Cover Wegovy for Weight Loss?
Yes, potentially through the Bridge.
Wegovy is currently among the products CMS lists for eligible beneficiaries under the Medicare GLP-1 Bridge.
But being prescribed Wegovy does not automatically make someone eligible.
You must satisfy the Part D, clinical and prior-authorization requirements.
Does Medicare Cover Zepbound for Weight Loss?
Yes, but the formulation matters.
CMS currently includes the Zepbound KwikPen under the Bridge.
CMS specifically states that the single-dose Zepbound pen and single-dose vials are not covered through the Bridge.
Does Medicare Advantage Cover the GLP-1 Bridge?
A person can potentially qualify while enrolled in an eligible Medicare Advantage plan if the plan includes qualifying Part D prescription-drug coverage and the other Bridge requirements are met.
However, CMS says certain special plan types are not eligible when they are the beneficiary’s only Medicare coverage, including certain:
- Private Fee-for-Service plans
- Cost contract plans
- PACE organizations
If you’re unsure about your exact plan type, Medicare recommends checking directly with Medicare.
What If I Get Extra Help?
The Medicare GLP-1 Bridge has an unusual rule for people receiving Extra Help.
CMS says the normal Part D low-income subsidy does not reduce the $50 Bridge copay.
Therefore, eligible Bridge beneficiaries generally pay the same $50 monthly copay regardless of income.
CMS says no Part D low-income subsidy applies to Bridge drugs because the demonstration operates outside the normal Part D payment flow.
Can I Use the Medicare Prescription Payment Plan for the $50?
No.
Medicare’s beneficiary fact sheet says drugs obtained through the Bridge are not eligible for the Medicare Prescription Payment Plan.
How Do I Apply for Medicare GLP-1 Coverage?
Check whether you have a standalone Medicare drug plan or eligible Medicare health plan with prescription-drug coverage.
If your Part D benefit already provides access, the Bridge generally isn’t the appropriate route.
Your provider can determine whether you satisfy the Bridge’s clinical criteria.
Bridge eligibility requires the appropriate authorization process.
If approved, obtain an eligible Bridge medication through a participating pharmacy.
What If My Pharmacy Says the GLP-1 Isn’t Covered?
Do not immediately assume Medicare has rejected all GLP-1 coverage.
Ask which issue caused the claim problem:
- Bridge prior authorization has not been approved.
- You do not meet the Bridge clinical criteria.
- The specific drug isn’t included.
- The formulation isn’t eligible.
- Your Part D plan already provides GLP-1 coverage.
- Your Medicare plan type isn’t eligible.
- The pharmacy needs to process the prescription through the correct route.
You can also contact Medicare for assistance.
How Long Will the Medicare GLP-1 Bridge Last?
CMS currently says the program runs through:
The Bridge was originally designed as a temporary demonstration. CMS subsequently extended it through the end of 2027.
Is the Medicare GLP-1 Bridge Available Nationwide?
The program is a federal Medicare demonstration rather than a state-by-state Medicaid coverage program.
That makes it fundamentally different from the Medicaid GLP-1 rules, which can vary substantially from one state to another.
Medicare vs. Medicaid GLP-1 Coverage
| Issue | Medicare | Medicaid |
|---|---|---|
| Weight-loss GLP-1 access | Eligible Part D beneficiaries may access selected drugs through the GLP-1 Bridge. | Depends heavily on state policy. |
| 2026 special program | Medicare GLP-1 Bridge | BALANCE participation may affect participating states. |
| Bridge cost | $50 per monthly supply | Not applicable |
| Prior authorization | Required for Bridge access. | Often required, depending on state/program. |
| Geographic rules | Federal Medicare program | Coverage varies significantly by state. |
Does Medicare Cover GLP-1 for Weight Loss? Quick Answers
| Question | Answer |
|---|---|
| Does Medicare cover GLP-1 for weight loss? | Eligible Part D beneficiaries can access certain drugs through the Medicare GLP-1 Bridge. |
| How much does the Bridge cost? | $50 per monthly supply. |
| When did it start? | July 1, 2026. |
| When does it currently end? | December 31, 2027. |
| Is Wegovy included? | Yes, for eligible beneficiaries under current Bridge rules. |
| Is Zepbound included? | Only the currently eligible KwikPen formulation. |
| Is Ozempic a Bridge weight-loss drug? | No, not under the current Bridge list. |
| Is Mounjaro a Bridge weight-loss drug? | No, not under the current Bridge list. |
| Does the Part D deductible apply? | No. |
| Does the $50 count toward TrOOP? | No. |
| Does Extra Help lower the $50? | No low-income subsidy applies to Bridge drugs. |
| Is prior authorization required? | Yes. |
Bottom Line
Medicare’s approach to GLP-1 drugs for weight loss changed in 2026 with the launch of the Medicare GLP-1 Bridge.
Eligible Medicare Part D beneficiaries can now obtain certain weight-management GLP-1 medications for a predictable $50 monthly copay.
Current eligible products include Foundayo, Wegovy and the Zepbound KwikPen.
But coverage is not automatic. Beneficiaries must meet the Bridge’s Part D and clinical eligibility rules and obtain prior authorization.
The $50 also operates outside normal Part D spending: the Part D deductible doesn’t apply, the payment doesn’t count toward TrOOP, and the Extra Help subsidy doesn’t lower the Bridge copay.
Because CMS can update the program and eligible drug list, check the current Medicare GLP-1 Bridge information before filling a prescription.
Official Sources
Medicare
Medicare GLP-1 Bridge
Centers for Medicare & Medicaid Services
CMS Medicare GLP-1 Bridge
Last reviewed: October 7, 2026. Medicare GLP-1 Bridge eligibility, clinical criteria and eligible medications can change. Check current Medicare guidance and discuss medication decisions with your healthcare professional. This article explains insurance coverage and is not medical advice. BillUnpacked is an independent informational website and is not affiliated with Medicare, CMS or any drug manufacturer.